Skip to main content

Diagnostic Evaluation of Pulmonary Disease Following Hematopoietic Stem Cell Transplantation

  • Chapter
  • First Online:
Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation
  • 384 Accesses

Abstract

Pulmonary diseases are frequent complications following hematopoietic stem cell transplantation (HSCT). They can be infectious and noninfectious, sometimes combined, and occur before and after engraftment. They may involve the bronchi, alveoli, and capillary vessels. They can occur after autologous and allogeneic HSCT with similarities but also differences which depend on various factors. Clinical presentations are diverse, and an accurate and timely differential diagnosis is essential.

The diagnostic evaluation should be systematic, from the least invasive to the most invasive, with pretest probability and risk over benefit ratio in mind. Diagnostics include complete cell count with differential, blood culture, nasopharyngeal swab, and urine antigens. Serum can be tested for viral and fungal markers, antinuclear antibodies, extractable nuclear antigen antibodies, and vasculitis panel. Pro-brain natriuretic peptide and echocardiogram may be helpful. Imaging may include chest radiograph and chest computed tomography. Bronchoscopy with bronchoalveolar lavage may be useful in challenging or unresolved situations. Tissue biopsy is rarely indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Wieruszewski PM, Herasevich S, Gajic O, Yadav H. Respiratory failure in the hematopoietic stem cell transplant recipient. World J Crit Care Med. 2018;7(5):62–72.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Saunders IM, Tan M, Koura D, Young R. Long-term follow-up of hematopoietic stem cell transplant survivors: a focus on screening, monitoring, and therapeutics. Pharmacotherapy. 2020;40(8):808–41.

    Article  PubMed  Google Scholar 

  3. Soubani AO. Critical care considerations of hematopoietic stem cell transplantation. Crit Care Med. 2006;34(9 Suppl):S251–67.

    Article  PubMed  Google Scholar 

  4. Peters SG, Afessa B. Acute lung injury after hematopoietic stem cell transplantation. Clin Chest Med. 2005;26(4):561–9. vi

    Article  PubMed  Google Scholar 

  5. Khayyata S, Soubani AO, Bonnett M, Nassar H, Abidi MH, Al-Abbadi MA. The major autopsy findings in adult patients after hematopoietic stem cell transplantation. Ann Transplant. 2007;12(2):11–8.

    PubMed  Google Scholar 

  6. Afessa B, Peters SG. Major complications following hematopoietic stem cell transplantation. Semin Respir Crit Care Med. 2006;27(3):297–309.

    Article  PubMed  Google Scholar 

  7. Schlemmer F, Chevret S, Lorillon G, De Bazelaire C, Peffault de Latour R, Meignin V, Michallet M, Hermet E, Wyplosz B, Houdouin V, Marchand-Adam S, Socié G, Tazi A, Bergeron A. Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation. Respir Med. 2014;108(10):1525–33.

    Article  PubMed  Google Scholar 

  8. Meignin V, Thivolet-Bejui F, Kambouchner M, Hussenet C, Bondeelle L, Mitchell A, Chagnon K, Begueret H, Segers V, Cottin V, Tazi A, Chevret S, Danel C, Bergeron A. Lung histopathology of non-infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation. Histopathology. 2018;73(5):832–42.

    Article  PubMed  Google Scholar 

  9. Gazourian L, Spring L, Meserve E, Hwang D, Diaz AA, Ash SY, Ho VT, Sholl LM, Washko GR. Pulmonary clinicopathological correlation after allogeneic hematopoietic stem cell transplantation: an autopsy series. Biol Blood Marrow Transplant. 2017;23(10):1767–72.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Afessa B, Abdulai RM, Kremers WK, Hogan WJ, Litzow MR, Peters SG. Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant. Chest. 2012;141(2):442–50.

    Article  PubMed  Google Scholar 

  11. Bergeron A, Chevret S, Peffault de Latour R, Chagnon K, de Margerie-Mellon C, Rivière F, Robin M, Mani J, Lorillon G, Socié G, Tazi A. Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation. Eur Respir J. 2018;51(5):1702617.

    Article  PubMed  Google Scholar 

  12. Haider S, Durairajan N, Soubani AO. Noninfectious pulmonary complications of haematopoietic stem cell transplantation. Eur Respir Rev. 2020;29(156):190119.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sharifi H, Lai YK, Guo H, Hoppenfeld M, Guenther ZD, Johnston L, Brondstetter T, Chhatwani L, Nicolls MR, Hsu JL. Machine learning algorithms to differentiate among pulmonary complications after hematopoietic cell transplant. Chest. 2020;158(3):1090–103.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;28(5):425–34.

    Article  CAS  PubMed  Google Scholar 

  15. Shiari A, Nassar M, Soubani AO. Major pulmonary complications following hematopoietic stem cell transplantation: what the pulmonologist needs to know. Respir Med. 2021;185:106493.

    Article  PubMed  Google Scholar 

  16. Bauer PR, Chevret S, Yadav H, Mehta S, Pickkers P, Bukan RB, Rello J, van de Louw A, Klouche K, Meert AP, Martin-Loeches I, Marsh B, Socias Crespi L, Moreno-Gonzalez G, Buchtele N, Amrein K, Balik M, Antonelli M, Nyunga M, Barratt-Due A, Bergmans DCJJ, Spoelstra-de Man AME, Kuitunen A, Wallet F, Seguin A, Metaxa V, Lemiale V, Burghi G, Demoule A, Karvunidis T, Cotoia A, Klepstad P, Møller AM, Mokart D, Azoulay E, Efraim Investigators and the Nine-I Study Group. Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy. Eur Respir J. 2019;54(1):1802442.

    Article  PubMed  Google Scholar 

  17. Feinstein MB, Habtes I, Giralt S, Stover DE. Utility of bronchoscopy with bronchoalveolar lavage among hematologic transplant recipients in the era of noninvasive testing. Respiration. 2021;100(4):339–46.

    Article  PubMed  Google Scholar 

  18. Bondeelle L, Bergeron A. Managing pulmonary complications in allogeneic hematopoietic stem cell transplantation. Expert Rev Respir Med. 2019;13(1):105–19.

    Article  CAS  PubMed  Google Scholar 

  19. Duque-Afonso J, Ewald S, Ihorst G, Waterhouse M, Struessmann T, Zeiser R, Wäsch R, Bertz H, Müller-Quernheim J, Duyster J, Finke J, Marks R, Engelhardt M. The impact of pulmonary function in patients undergoing autologous stem cell transplantation. Blood Adv. 2021;5(21):4327–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Diab KJ, Yu Z, Wood KL, Shmalo JA, Sheski FD, Farber MO, Wilkes DS, Nelson RP Jr. Comparison of pulmonary complications after nonmyeloablative and conventional allogeneic hematopoietic cell transplant. Biol Blood Marrow Transplant. 2012;18(12):1827–34.

    Article  PubMed  Google Scholar 

  21. Lichtenstein DA. BLUE-protocol and FALLS-protocol: two applications of lung ultrasound in the critically ill. Chest. 2015;147(6):1659–70.

    Article  PubMed  Google Scholar 

  22. Sirithanakul K, Salloum A, Klein JL, Soubani AO. Pulmonary complications following hematopoietic stem cell transplantation: diagnostic approaches. Am J Hematol. 2005;80(2):137–46.

    Article  PubMed  Google Scholar 

  23. Harris B, Geyer AI. Diagnostic evaluation of pulmonary abnormalities in patients with hematologic malignancies and hematopoietic cell transplantation. Clin Chest Med. 2017;38(2):317–31.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Lucena CM, Torres A, Rovira M, Marcos MA, de la Bellacasa JP, Sánchez M, Domingo R, Gabarrus A, Mensa J, Agustí C. Pulmonary complications in hematopoietic SCT: a prospective study. Bone Marrow Transplant. 2014;49(10):1293–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. O'Dwyer DN, Duvall AS, Xia M, Hoffman TC, Bloye KS, Bulte CA, Zhou X, Murray S, Moore BB, Yanik GA. Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation. Bone Marrow Transplant. 2018;53(2):193–8.

    Article  CAS  PubMed  Google Scholar 

  26. Dieffenbach BV, Madenci AL, Murphy AJ, Weldon CB, Weil BR, Lehmann LE. Therapeutic impact and complications associated with surgical lung biopsy after allogeneic hematopoietic stem cell transplantation in children. Biol Blood Marrow Transplant. 2019;25(11):2181–5.

    Article  PubMed  Google Scholar 

  27. Jantunen E, Piilonen A, Volin L, Ruutu P, Parkkali T, Koukila-Kähkölä P, Ruutu T. Radiologically guided fine needle lung biopsies in the evaluation of focal pulmonary lesions in allogeneic stem cell transplant recipients. Bone Marrow Transplant. 2002;29(4):353–6.

    Article  CAS  PubMed  Google Scholar 

  28. de Oliveira RM, de Almeida Testa LH, Dos Santos ACF, Zanetti LP, da Silva RL, de Souza MP, Colturato VR, Machado CM. Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study. Bone Marrow Transplant. 2021;56(9):2241–7.

    Article  Google Scholar 

  29. Jaskula E, Dlubek D, Sedzimirska M, Duda D, Tarnowska A, Lange A. Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation. Transplant Proc. 2010;42(8):3273–6.

    Article  CAS  PubMed  Google Scholar 

  30. Vakil E, Evans SE. Viral pneumonia in patients with hematologic malignancy or hematopoietic stem cell transplantation. Clin Chest Med. 2017;38(1):97–111.

    Article  PubMed  Google Scholar 

  31. Pegoraro F, Favre C. Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation. Ann Hematol. 2021;100(4):865–78.

    Article  PubMed  Google Scholar 

  32. Young AY, Leiva Juarez MM, Evans SE. Fungal pneumonia in patients with hematologic malignancy and hematopoietic stem cell transplantation. Clin Chest Med. 2017;38(3):479–91.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DP. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis. 2011;52(9):1144–55.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Wirk B, Wingard JR. Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation. Transpl Infect Dis. 2009;11(2):143–8.

    Article  CAS  PubMed  Google Scholar 

  35. Zhang Z, Wang C, Peters SG, Hogan WJ, Hashmi SK, Litzow MR, Patnaik MS, Niven AS, Yadav H. Epidemiology, risk factors, and outcomes of diffuse alveolar Hemorrhage after hematopoietic stem cell transplantation. Chest. 2021;159(6):2325–33.

    Article  CAS  PubMed  Google Scholar 

  36. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–33.

    Google Scholar 

  37. Yadav H, Nolan ME, Bohman JK, Cartin-Ceba R, Peters SG, Hogan WJ, Gajic O, Kor DJ. Epidemiology of acute respiratory distress syndrome following hematopoietic stem cell transplantation. Crit Care Med. 2016;44(6):1082–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Nguyen LP, Ahdoot S, Sriratanaviriyakul N, Zhang Y, Stollenwerk N, Schivo M, Harper R. Acute fibrinous and organizing pneumonia associated with allogenic hematopoietic stem cell transplant successfully treated with corticosteroids: a two-patient case series. J Investig Med High Impact Case Rep. 2016;4(2):2324709616643990.

    PubMed  PubMed Central  Google Scholar 

  39. Chang L, Frame D, Braun T, Gatza E, Hanauer DA, Zhao S, Magenau JM, Schultz K, Tokala H, Ferrara JL, Levine JE, Reddy P, Paczesny S, Choi SW. Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes. Biol Blood Marrow Transplant. 2014;20(9):1407–17.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Grant A, Chapman LRM, Mitchell R, O'Brien TA. Engraftment syndrome following hematopoietic stem cell transplant: a review of the literature. Clin Transpl. 2020;34(6):e13875.

    Article  Google Scholar 

  41. Panoskaltsis-Mortari A, Griese M, Madtes DK, Belperio JA, Haddad IY, Folz RJ, Cooke KR, American Thoracic Society Committee on Idiopathic Pneumonia Syndrome. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med. 2011;183(9):1262–79.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21(3):389–401.e1.

    Article  PubMed  Google Scholar 

  43. Dudek AZ, Mahaseth H. Hematopoietic stem cell transplant-related airflow obstruction. Curr Opin Oncol. 2006;18(2):115–9.

    Article  PubMed  Google Scholar 

  44. Bergeron A, Bengoufa D, Feuillet S, Meignin V, de Latour RP, Rybojad M, Gossot D, Azoulay E, Socié G, Tazi A. The spectrum of lung involvement in collagen vascular-like diseases following allogeneic hematopoietic stem cell transplantation: report of 6 cases and review of the literature. Medicine (Baltimore). 2011;90(2):146–57.

    Article  PubMed  Google Scholar 

  45. Salvator H, Tcherakian C, Maillard N, Milin S, Bergeron A, Bondeelle L, Meignin V, Nguyen S, Souchet L, Guenounou S, Evrard SM, Rubio MT, Robin M, Sestili S, Brissot E, Fajac A, Catherinot E, Givel C, Chabrol A, Goyard C, Longchampt E, Chabi-Charvillat ML, Bernaudin JF, Couderc LJ. Pulmonary alveolar proteinosis after allogeneic hematopoietic stem-cell transplantation in adults: a French Societe francophone de Greffe de Moelle et Therapie Cellulaire survey. Chest. 2021;160(5):1783–8.

    Article  PubMed  Google Scholar 

  46. Dandoy CE, Hirsch R, Chima R, Davies SM, Jodele S. Pulmonary hypertension after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19(11):1546–56.

    Article  PubMed  Google Scholar 

  47. Sahin U, Ataca Atilla P, Atilla E, Toprak SK, Demirer T. An overview of hematopoietic stem cell transplantation related thrombotic complications. Crit Rev Oncol Hematol. 2016;107:149–55.

    Article  PubMed  Google Scholar 

  48. Peters A, Manivel JC, Dolan M, Gulbahce HE, Baker KS, Verneris MR. Pulmonary cytolytic thrombi after allogeneic hematopoietic cell transplantation: a further histologic description. Biol Blood Marrow Transplant. 2005;11(6):484–5.

    Article  PubMed  Google Scholar 

  49. Woodard JP, Gulbahce E, Shreve M, Steiner M, Peters C, Hite S, Ramsay NK, DeFor T, Baker KS. Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation. Bone Marrow Transplant. 2000;25(3):293–300.

    Article  CAS  PubMed  Google Scholar 

  50. Mattei D, Feola M, Orzan F, Mordini N, Rapezzi D, Gallamini A. Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient. Bone Marrow Transplant. 2009;43(12):967–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philippe R. Bauer .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bauer, P.R. (2023). Diagnostic Evaluation of Pulmonary Disease Following Hematopoietic Stem Cell Transplantation. In: Soubani, A.O. (eds) Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-031-28797-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-28797-8_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-28796-1

  • Online ISBN: 978-3-031-28797-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics